Тип публикации: статья из журнала
Год издания: 2009
Идентификатор DOI: 10.1007/s10517-010-0787-5
Ключевые слова: Apoptosis, Cyclophosphamide, Melatonin, Proteins of the Bcl-2 family, Walker 256 carcinosarcoma, cytostatic agent, protein BAD, protein Bax, protein bcl 2, animal experiment, article, cancer combination chemotherapy, cancer regression, cancer transplantation, carcinogenesis, controlled study, immunohistochemistry, male, monotherapy, nonhuman, protein expression, protein family, rat, Walker carcinoma, Wistar rat, Animals, Antineoplastic Agents, Alkylating, Antioxidants, bcl-2-Associated X Protein, bcl-Associated Death Protein, Carcinoma 256, Walker, Cytostatic Agents, Humans, Neoplasm Transplantation, Proto-Oncogene Proteins c-bcl-2, Rats, Rats, Wistar, Tumor Cells, Cultured, Rattus norvegicus
Аннотация: Immunohistochemical study was performed to evaluate the expression of Bcl-2 family proteins (Bcl-2, Bax, and Bad) in Walker 256 carcinosarcoma cells after implantation into the thigh muscle of male Wistar rats (106 cells). The experiment was conducted under conditions of spontaneous tumor development and individual or combined treaПоказать полностьюtment with melatonin and cyclophosphamide. The use of melatonin as monotherapy or in combination with cyclophosphamide was followed by a signifi cant decrease in Bcl-2 expression in carcinosarcoma cells. The Bcl-2/Bax and Bcl-2/Bad ratio was signifi cantly reduced under these conditions (particularly after combined treatment with cytostatic drugs). These changes were accompanied by a signifi cant (by 93.61%) decrease in the volume of transplantable tumor on day 14. Daily treatment with melatonin was accompanied by signifi cant changes in the structure of Walker 256 carcinosarcoma. It was manifested in the formation of connective tissue septa and pseudofollicles. © 2009 Springer Science+Business Media, Inc.
Журнал: Bulletin of Experimental Biology and Medicine
Выпуск журнала: Vol. 148, Is. 4
Номера страниц: 650-655